Hims & Hers Health Inc Stock Price, News & Analysis

Hims & Hers Health reported Q2 2022 revenue of $113.6 million, marking an 87% year-over-year increase. The company achieved over 100k net new subscriptions, totaling 817,000, an 80% increase from the previous year. Hims & Hers raised its full-year 2022 revenue guidance to $470 million to $485 million, with an adjusted EBITDA forecast of $(27) million to $(20) million. The company anticipates adjusted EBITDA profitability within the next four quarters, driven by operational efficiencies and strong platform demand.

Hims & Hers Health, Inc. will announce its second quarter 2022 financial results on August 8, 2022, at 4:15 p.m. E.T.. A conference call will follow at 5:00 p.m. E.T. Participants can join by dialing +1 (888) 510-2630 for U.S. callers or +1 (646) 960-0137 for international callers, with the conference ID #1704296. The call will also be available via a live audio webcast. Hims & Hers offers a multi-specialty telehealth platform and serves a variety of health needs, with operations in the U.S. and the U.K.

Hims & Hers Health, Inc. has launched a new line of supplements, Hers Wellness Essentials, specifically designed for women. The six products target various health concerns, including general health, mental wellness, gut health, digestive health, skin health, and libido. Available at CVS Pharmacy and other online platforms, these gluten-free, non-GMO, and vegetarian supplements utilize effective, naturally occurring ingredients. This expansion signifies Hims & Hers' commitment to offering personalized wellness options tailored to women's unique health needs.

Hims & Hers reported Q1 2022 revenue of $101.3 million, a 94% increase year-over-year, surpassing the $100 million mark for the first time. The company also achieved a net loss of $(16.3) million, improved from $(51.4) million in Q1 2021. Member subscriptions grew by 101,000 to 710,000, an 82% increase. The company raised its full year 2022 revenue guidance to between $410 million and $425 million, while maintaining Adjusted EBITDA guidance of $(30 million) to $(20 million).

Hims & Hers Health, Inc. (NYSE: HIMS) will report its Q1 2022 financial results on May 9, 2022, at 4:15 p.m. E.T., followed by a conference call at 5:00 p.m. E.T. Participants can dial +1 (888) 510-2630 for U.S. access or +1 (646) 960-0137 for international access, using conference ID #1704296. A live audio webcast will be available at investors.forhims.com, with a replay accessible for 12 months.

Hims & Hers is a telehealth platform offering diverse healthcare services and can be accessed via a mobile app and retail locations across the U.S. and the U.K.

Hims & Hers has formed a partnership with Carbon Health to enhance its telehealth platform, now active in seven U.S. states. This collaboration aims to provide patients with broader access to personalized healthcare for complex conditions. Licensed professionals on the Hims & Hers platform will refer patients needing comprehensive care to Carbon Health. This partnership reflects Hims & Hers' strategy to improve healthcare delivery and patient outcomes by combining digital and in-person services, ultimately creating a more integrated healthcare system.

Hims & Hers Health, Inc. (NYSE: HIMS) has expanded its skincare collection, introducing new products aimed at addressing various skincare concerns. The lineup includes a facial cleanser, moisturizer, daily SPF, spot corrector, and face oil, formulated to avoid irritants and unnecessary fragrances. Co-founder Hilary Coles emphasized the brand's focus on personalized skincare experiences. The new products are now available at select CVS Pharmacy locations and through the company's websites, aiming to enhance consumer accessibility to effective skincare options.

Hims & Hers Health, Inc. (NYSE: HIMS) announced a partnership with Goodpath to enhance its mobile app offering. This collaboration will provide Hims & Hers members access to curated educational content regarding sleep, musculoskeletal issues, back pain, and gastroesophageal reflux disease (GERD). The app will feature programming tailored by medical advisors to better support users facing these health concerns. With a focus on personalized health and wellness experiences, this initiative aims to further improve the quality of care for the 500,000 subscription members.

Hims & Hers Health has appointed Amee Parekh as the new Senior Vice President of Human Resources. With a strong background in scaling high-growth companies, including her previous role at Uber, Parekh is set to enhance Hims & Hers' rapid growth trajectory. The company reported an impressive revenue increase of 83% year-over-year in 2021, totaling $271.9 million, alongside a 95% growth in member subscriptions in Q4 2021. This hire comes amid a series of leadership changes aimed at fostering a robust organizational structure for further expansion.